首页 > 市场调查报告书 > 製药

呼吸器

肺炎检测市场规模、份额和成长分析（按产品类型、类型、最终用户和地区划分）－2026-2033年产业预测

市场调查报告书

商品编码

1900217

肺炎检测市场规模、份额和成长分析（按产品类型、类型、最终用户和地区划分）－2026-2033年产业预测

Pneumonia Testing Market Size, Share, and Growth Analysis, By Product Type (Reagents & Consumables, Instruments), By type (Streptococcus-Based, Viral Pneumonia-Based), By End User, By Region -Industry Forecast 2026-2033

出版日期: 2025年12月24日 | 出版商:

SkyQuest | 英文 219 Pages | 商品交期: 3-5个工作天内

价格

简介目录

预计到 2024 年，肺炎检测市场规模将达到 5.9659 亿美元，到 2025 年将达到 6.3596 亿美元，到 2033 年将达到 10.6045 亿美元，预测期（2026-2033 年）的复合年增长率为 6.6%。

由于肺炎发病率上升和早期诊断技术的进步，肺炎检测市场正经历显着增长。受疫情影响，病毒性肺炎病例激增，人们对肺炎检测的关注度也随之提高。虽然新冠肺炎带来了新的肺炎风险，但封锁措施却意外地减少了本地传播病例。技术进步，特别是核酸检测技术的进步，以及政府和非政府组织为提高公众意识和推广正确诊断所做的努力，也推动了市场成长。贫穷问题导致发展中国家肺炎相关死亡率居高不下，促使各国政府实施旨在提高公众意识和提升诊断能力的计画。此外，已开发国家对肺炎检测指南的遵循也可能进一步推动这个重要市场的成长。

肺炎检测市场驱动因素

全球肺炎检测市场的主要驱动因素之一是肺炎发病率的不断上升，尤其是在婴幼儿、老年人和免疫系统较弱等弱势群体中。肺炎病例的增加推动了对精准诊断工具和检测方案的需求，因为及时准确地识别疾病对于有效治疗和管理至关重要。此外，医疗技术的进步，包括快速诊断测试和分子技术的开发，提高了快速诊断各种类型肺炎的能力。随着医疗机构寻求更有效的方法来对抗这种感染疾病，这些技术创新进一步推动了市场成长。

肺炎检测市场的限制

全球肺炎检测市场的主要限制因素之一是先进诊断技术和设备的高成本。肺炎检测的复杂性通常需要专门的实验室和训练有素的人员，这可能会限制其普及，尤其是在中低收入国家。此外，大众对肺炎症状缺乏认识和了解，可能导致诊断和后续检测延误，进一步阻碍市场成长。医疗机构面临的预算限制也阻碍了创新检测方案的采用，导致其依赖传统方法，而这些方法在准确诊断肺炎方面可能效果不佳。

肺炎检测市场趋势

肺炎检测市场正经历一场由自动化和人工智慧融合驱动的变革。这些先进技术提高了检测资料处理的速度和准确性，使医疗专业人员能够更有效率、更自信地解读结果。基于人工智慧的系统正被越来越多地用于最大限度地减少诊断中的人为错误，从而提高肺炎患者的护理标准。这种创新技术的整合不仅简化了临床工作流程，还支援更有效的治疗通讯协定，使自动化和人工智慧驱动的解决方案成为肺炎调查方法发展的核心要素。

北美洲
- 美国
- 加拿大
欧洲
- 德国
- 西班牙
- 法国
- 英国
- 义大利
- 其他欧洲地区
亚太地区
- 中国
- 印度
- 日本
- 韩国
- 亚太其他地区
拉丁美洲
- 巴西
- 其他拉丁美洲地区
中东和非洲（MEA）
- 海湾合作委员会国家
- 南非
- 其他中东和非洲地区

竞争格局

前五大公司对比
主要企业的市场定位（2025 年）
主要市场参与者所采取的策略
近期市集活动
主要企业市占率（2025 年）

主要企业简介

Thermo Fisher Scientific Inc.（US）
Quidel Corporation（US）
Becton, Dickinson, and Company（US）
Meridian Bioscience, Inc.（US）
Qiagen NV（Netherlands）
bioMerieux SA（France）
Bio-Rad Laboratories Inc.（US）
Cardinal Health Inc.（US）
Hologic Inc.（US）
La Roche Ltd.（Switzerland）
Abbott Laboratories（US）
Quest Diagnostics（US）
Luminex Corporation（US）
F. Hoffmann-La Roche Ltd.（Switzerland）
Agena Bioscience, Inc.（US）
Roche Diagnostics（Switzerland）
Grifols, SA（Spain）
PerkinElmer, Inc.（US）
Genoa Healthcare, LLC（US）
SeraCare Life Sciences, Inc.（US）
Randox Laboratories Ltd.（UK）
Acon Laboratories, Inc.（US）

简介目录

Product Code: SQMIG35D2250

Pneumonia Testing Market size was valued at USD 596.59 Million in 2024 and is poised to grow from USD 635.96 Million in 2025 to USD 1060.45 Million by 2033, growing at a CAGR of 6.6% during the forecast period (2026-2033).

The pneumonia testing market is experiencing significant growth, driven by the increasing incidence and early diagnosis of the disease. The rise in viral pneumonia cases, exacerbated by the pandemic, has heightened awareness around pneumonia testing. While COVID-19 introduced additional pneumonia risks, lockdowns inadvertently led to decreased community-acquired cases. Advancements in technology, specifically nucleic acid detection, coupled with efforts from both governmental and non-governmental organizations to enhance awareness and promote proper diagnosis, are also propelling market growth. In less developed regions, poverty-related issues contribute to high pneumonia-related mortality rates, prompting governments to implement programs aimed at improving awareness and diagnostic capabilities. Moreover, adherence to pneumonia testing guidelines in developed nations is likely to foster further growth in this vital market.

Top-down and bottom-up approaches were used to estimate and validate the size of the Pneumonia Testing market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Pneumonia Testing Market Segments Analysis

Global Pneumonia Testing Market is segmented by Product Type, Type, End-user, and region. Based on Product Type, the market is segmented into Instruments, Reagents & Consumables. Based on Type, the market is segmented into Streptococcus-based, Legionella-based, Chlamydophila-based, Viral Pneumonia-based, Mycoplasma Pneumonia-based, Others. Based on End-user, the market is segmented into Hospitals & Clinics, Diagnostic Centers, and Others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & and Africa.

Driver of the Pneumonia Testing Market

One key market driver for the global pneumonia testing market is the increasing prevalence of pneumonia, especially among vulnerable populations such as infants, the elderly, and individuals with compromised immune systems. This rise in pneumonia cases fuels the demand for accurate diagnostic tools and testing solutions, as timely and precise identification of the disease is critical for effective treatment and management. Additionally, advancements in medical technology, including the development of rapid diagnostic tests and molecular techniques, enhance the ability to quickly diagnose various pneumonia types, further supporting market growth as healthcare providers seek efficient methods to combat this infectious disease.

Restraints in the Pneumonia Testing Market

One significant market restraint for the global pneumonia testing market is the high cost associated with advanced diagnostic technologies and equipment. The complexity of pneumonia testing often requires specialized laboratories and trained personnel, which can limit accessibility, particularly in low- and middle-income countries. Additionally, the lack of awareness and understanding of pneumonia symptoms among the general population may lead to delayed diagnoses and subsequent testing, further hindering market growth. Budget constraints faced by healthcare facilities can also impede the adoption of innovative testing solutions, leading to reliance on traditional methods that may be less effective in accurately diagnosing pneumonia.

Market Trends of the Pneumonia Testing Market

The pneumonia testing market is witnessing a transformative trend driven by the integration of automation and artificial intelligence. These advanced technologies enhance the speed and accuracy of test data processing, allowing healthcare professionals to interpret results with greater efficiency and reliability. AI-based systems are increasingly being utilized to minimize human errors in diagnostics, thereby elevating the standard of care for pneumonia patients. This convergence of innovation not only streamlines workflows within clinical settings but also supports more effective treatment protocols, positioning automated and AI-driven solutions as pivotal components in the evolution of pneumonia testing methodologies.

Introduction

Objectives of the Study
Definitions
Market Scope

Research Methodology

Information Procurement
Secondary & Primary Data Sources
Market Size Estimation
Market Assumptions & Limitations

Executive Summary

Market Overview Outlook
Supply Demand Trend Analysis
Segmental Opportunity Analysis

Market Dynamics & Outlook

Market Dynamics
- Drivers
- Opportunities
- Restraints
- Challenges
Porters Analysis
- Competitive rivalry
- Threat of Substitute Products
- Bargaining Power of Buyers
- Threat of New Entrants
- Bargaining Power of Suppliers

Key Market Insights

Technology Analysis
Value Chain Analysis
Ecosystem of the Market
Case study Analysis
Regulatory Landscape
Innovation Matrix
Top Investment Analysis
Key Success Factor
Degree of Competition
PESTEL Analysis

Pneumonia Testing Market by Product Type

Market Overview
Instruments
Reagents & Consumables

Pneumonia Testing Market by Type

Market Overview
Streptococcus-based
Legionella-based
Chlamydophila-based
Viral Pneumonia-based
Mycoplasma Pneumonia-based
Others

Pneumonia Testing Market by End-user

Market Overview
Hospitals & Clinics
Diagnostic Centers
Others

Pneumonia Testing Market Market Size by Region

Market Overview
North America
- USA
- Canada
Europe
- Germany
- Spain
- France
- UK
- Italy
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Rest of Asia-Pacific
Latin America
- Brazil
- Rest of Latin America
Middle East & Africa (MEA)
- GCC Countries
- South Africa
- Rest of MEA

Competitive Landscape

Top 5 Player Comparison
Market Positioning of Key Players, 2025
Strategies Adopted by Key Market Players
Recent Activities in the Market
Key Companies Market Share (%), 2025

Key Company Profiles

Thermo Fisher Scientific Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quidel Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Becton, Dickinson, and Company (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Meridian Bioscience, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Qiagen N.V. (Netherlands)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
bioMerieux SA (France)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Bio-Rad Laboratories Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Cardinal Health Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Hologic Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Abbott Laboratories (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Quest Diagnostics (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Luminex Corporation (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
F. Hoffmann-La Roche Ltd. (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Agena Bioscience, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Roche Diagnostics (Switzerland)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Grifols, S.A. (Spain)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
PerkinElmer, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Genoa Healthcare, LLC (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
SeraCare Life Sciences, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Randox Laboratories Ltd. (UK)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments
Acon Laboratories, Inc. (US)
- Company Overview
- Business Segment Overview
- Financial Updates
- Key Developments

02-2729-4219

+886-2-2729-4219

License/价格

肺炎检测市场规模、份额和成长分析（按产品类型、类型、最终用户和地区划分）－2026-2033年产业预测

Pneumonia Testing Market Size, Share, and Growth Analysis, By Product Type (Reagents & Consumables, Instruments), By type (Streptococcus-Based, Viral Pneumonia-Based), By End User, By Region -Industry Forecast 2026-2033

目录

介绍

调查方法

执行摘要

市场动态与展望

关键市场考察

肺炎检测市场依产品类型划分

肺炎检测市场按类型划分

肺炎检测市场依最终用户划分

肺炎检测市场：按地区分類的市场规模：

竞争格局